Looks like fund selling to me.
In liquidation mode.
Another RAD ?
I don't think so. CVB is at the start of commercialisation with FDA approval and Stryker partnership. The big advantage in comparison to EMV is the partnership and most importantly reimbursement.
- Forums
- ASX - By Stock
- Expectations - short term
Looks like fund selling to me.In liquidation mode.Another RAD ?I...
Featured News
Add CVB (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $34.93M |
Open | High | Low | Value | Volume |
10.5¢ | 12.0¢ | 10.5¢ | $9.142K | 80.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 68823 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 71158 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 68823 | 0.105 |
4 | 123584 | 0.100 |
2 | 18594 | 0.098 |
3 | 231505 | 0.095 |
1 | 24829 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 71158 | 2 |
0.135 | 7400 | 1 |
0.140 | 120000 | 2 |
0.155 | 54493 | 1 |
0.175 | 5719 | 1 |
Last trade - 12.47pm 13/11/2024 (20 minute delay) ? |
Featured News
CVB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online